(Reuters) – ConvaTec‘s owners have appointed Morgan Stanley and Goldman Sachs to explore a sale of the medical device maker which could be worth up to $10 billion, sources familiar with the matter said.
3m
Pentagon awards $78m in contracts to 5 medtech companies
ConvaTec said to explore 2015 sale
Podcast: Medical device execs react to Medtronic-Covidien deal, M&A activity at DeviceTalks Minnesota
Medtech gets a nod in Minnesota’s Super Bowl pitch | MassDevice.com On Call
MASSDEVICE ON CALL — The Minnesota Vikings highlighted some of their state’s most prominent features in order to win over the Super Bowl selection committee, including some of the North Star State’s most prominent medical device makers.
Study: Abbott, Johnson & Johnson park billions in offshore tax havens
Medical device tax: Congressional duo launches tax reform tour
Medical device industry lobbying groups rallied behind Sen. Max Baucus (D-Mont.) and Rep. Dave Camp (R-Mich.) as the Congressional duo embarked on a nation-wide tax reform tour, a possible boon to efforts to repeal the medical device tax.
Report: CMS Innovation Center’s 1st chief on the way out
Dr. Richard Gilfillan, the 1st leader of the recently-created Center for Medicare & Medicaid Services Innovation Center, will hand over the reigns at the end of the month, and no replacement has yet been named.
Novation cuts new deals with medical device giants
Legal: 3M goes after Rocky Mountain Orthodontics
Medical device companies: Who spends the most on R&D?
Across the medical device industry, R&D spending in 2011 increased despite a lethargic economy, job cuts and reorganization mandates by a number of big-name companies.